Anaeropharma Science is based in Tokyo, Japan. It has raised $13M in total funding. Latest round: Growth.
Anaeropharma Science funding overview
Anaeropharma Science is based in Tokyo, Japan. Anaeropharma Science has raised $13M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Growth announced in July 2017. The round record for Anaeropharma Science runs through 2017; nothing later has been disclosed. Investors on record include Novartis, Shinsei Corporate Investment Limited, Seventure Partners, Innovation Network Corporation of Japan, Mitsubishi UFJ Capital. 5 distinct backers are named across the disclosed rounds.
Anaeropharma Science at a glance
Total raised
$13M
Latest round
Growth
Latest round date
July 2017
Headquarters
Tokyo, Japan
Notable investors
Novartis, Shinsei Corporate Investment Limited, Seventure Partners, Innovation Network Corporation of Japan, Mitsubishi UFJ Capital
Frequently asked about Anaeropharma Science funding
How much has Anaeropharma Science raised?
Anaeropharma Science has raised $13M in total disclosed funding across the rounds on record.
Who has invested in Anaeropharma Science?
Novartis, Shinsei Corporate Investment Limited, Seventure Partners, Innovation Network Corporation of Japan, Mitsubishi UFJ Capital are named among the investors backing Anaeropharma Science.
What was the latest Anaeropharma Science funding round?
The most recent disclosed round is a Growth, announced in July 2017.
Where is Anaeropharma Science based?
Anaeropharma Science is based in Tokyo, Japan.
When did Anaeropharma Science last raise?
The last disclosed Anaeropharma Science round closed in July 2017 at Growth.
Totals shown for Anaeropharma Science aggregate every disclosed round on file. To see how that compares, browse the companies in Tokyo and the investors behind them below.
